A Randomized Double-Blind, Placebo-Controlled Study of Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
A Randomized Double-Blind, Placebo-Controlled Study of Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
There are no treatments specifically approved after recurrence or progression on a non steroidal aromatase inhibitors (NSAI). In light of the need for new treatment options for postmenopausal women after failure of prior NSAI therapy, the purpose of this Phase III study is to compare efficacy and safety of a treatment with exemestane + everolimus to exemestane + placebo in postmenopausal women with estrogen receptor positive locally advanced or metastatic breast cancer refractory to NSAI.
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply
Anaheim, California 92807, United States
Grass Valley, California 95945, United States
Los Angeles, California 90053, United States
San Francisco, California 94101, United States
Santa Monica, California 90404, United States
Louisville, Kentucky 40202, United States
Baton Rouge, Louisiana 70808, United States
Metairie, Louisiana 70006, United States
Annapolis, Maryland 21401, United States
St Louis, Missouri 63141, United States
Albuquerque, New Mexico 87131, United States
Lawton, Oklahoma 73505, United States
Hershey, Pennsylvania 17033-0850, United States
Charleston, South Carolina 29425, United States
Nashville, Tennessee 37203, United States
Dallas, Texas 75390-8852, United States
Fort Worth, Texas 76104, United States
Houston, Texas 77030-4009, United States
Salt Lake City, Utah 84112, United States
Reston, Virginia 20190, United States
Madison, Wisconsin 53792, United States
Menoufiya, Egypt, Egypt
Saint-Herblain Cédex, 44805, France
Hong Kong SAR, Hong Kong
Antella - Bagno A Ripoli, FI 50011, Italy
Kitaadachi-gun, Saitama 362-0806, Japan
Bunkyo-ku, Tokyo 113-8677, Japan
Chuo-ku, Tokyo 104-0045, Japan
Chuo-ku, Tokyo 104-8560, Japan
Koto, Tokyo 135-8550, Japan
Sittard-Geleen, 6162 BG, Netherlands
Lørenskog, NO-1478, Norway
Hwasun-gun, Jeollanam-do 58128, South Korea
Mallorca, Balearic Islands 07198, Spain